Tax & FinanceNational-Nov 19, 2026

Medical Marijuana Companies Sue DEA In Federal Court Over Restrictions It Imposed For Rescheduling Protections

Key Takeaway

Three marijuana companies are taking the Drug Enforcement Administration (DEA) to court over restrictions the agency is placing on cannabis businesses under the Trump administration's federal rescheduling move. Last month, DEA announced it had granted federal registration and protections to hundreds of medical marijuana businesses in line with rescheduling while also issuing new guidance warning

What This Means for Cannabis Businesses

Tax developments like this directly impact the bottom line for every cannabis operator. With Section 280E creating effective tax rates above 70% for many businesses, any shift in federal tax policy - whether through rescheduling, court rulings, or IRS guidance - can mean the difference between profitability and closure. Cannabis business owners should work closely with a specialized CPA to understand how these changes affect their specific situation.

This analysis is based on reporting by Marijuana Moment. Read the original article. CannaBizGuide provides original commentary and analysis - this is not legal or tax advice.